keynote presentation: otis w. brawley, md, facp

28
Otis W. Brawley, MD, FACP Chief Medical and Scientific Officer American Cancer Society Professor of Hematology, Medical Oncology, Medicine and Epidemiology Emory University

Upload: informed-medical-decisions-foundation

Post on 23-Jun-2015

397 views

Category:

Health & Medicine


2 download

DESCRIPTION

2012 Summer Medical Editors Meeting: Otis W. Brawley, MD, FACP (Keynote Speaker)

TRANSCRIPT

Page 1: Keynote Presentation: Otis W. Brawley, MD, FACP

Otis W. Brawley, MD, FACP

Chief Medical and Scientific Officer American Cancer Society

Professor of Hematology, Medical Oncology, Medicine and Epidemiology

Emory University

Page 2: Keynote Presentation: Otis W. Brawley, MD, FACP

The  American  Cancer  Society  

We  are  dedicated  to  helping  People:  •    Get  Well  •    Stay  Well  •    Find  Cures  •    Fight  Back    

Page 3: Keynote Presentation: Otis W. Brawley, MD, FACP
Page 4: Keynote Presentation: Otis W. Brawley, MD, FACP

Prostate  Cancer  and  Chemopreven@on    •  Pretend  you  are  a  55  year  old  male  and  a  preven@ve  pill  exists:  –  If  you  take  the  pill  it  will  definitely  double  your  risk  of  prostate  cancer  diagnosis  from  10%  life@me  to  20%  life@me.  

–  It  you  take  it,  it  may  decrease  your  life@me  risk  of  prostate  cancer  death  by  20%  from  3%  to  2.4%  

•  Would  you  take  this  pill?  

Page 5: Keynote Presentation: Otis W. Brawley, MD, FACP

Otis W. Brawley, MD, FACP

Chief Medical and Scientific Officer American Cancer Society

Professor of Hematology, Medical Oncology, Medicine and Epidemiology

Emory University

Page 6: Keynote Presentation: Otis W. Brawley, MD, FACP

U.S.  Health  Care  Spending  

In  2009,  the  U.S.  spent  

$2.53  TRILLION    on  Health  Care  

Page 7: Keynote Presentation: Otis W. Brawley, MD, FACP

U.S.  Health  Care  Spending  

• How  Big  is  a  Trillion?      1  million  seconds    Last  week  

   1  billion  seconds    Richard  Nixon’s    Resigna@on    

   1  trillion  seconds    30,000  BCE  

Page 8: Keynote Presentation: Otis W. Brawley, MD, FACP

Spending  in  Context  

2009

* Excludes alcoholic beverages ($150 billion) and tobacco products ($92 billion) Source: Bureau of Economic Analysis; National Bureau of Statistics of China, MGI analysis

17.30%  

$2.53 trillion

$1.1 trillion

$1.4 trillion

Gross Domestic Product

Page 9: Keynote Presentation: Otis W. Brawley, MD, FACP

American  Healthcare  

•  16.2%  of  GDP  in  2008  •  17.3%  of  GDP  in  2009  •  19.3%  of  GDP  by  2019  (projected)  •  25%    of  GDP  by  2025  (projected)  

Page 10: Keynote Presentation: Otis W. Brawley, MD, FACP

Higher  Per  Capita  Spending  in  the  U.S.  does  not  Translate  into  Longer  Life  Expectancy  The Cost of a Long Life

Life Expectancy – Per Capita Spending

2006 CIA FACTBOOK

Ave

rage

Life

Exp

ecta

ncy

(yea

rs)

Per C

apita

Spe

ndin

g in

USD

74

75

76

77

78

79

80

81

82

Japa

n

San M

arino

Monac

o

Switzerl

and

Austra

lia

Sweden

Icelan

d

Andorr

a

Canad

aFran

ce Italy

Austria

Spain

Norway

Singap

ore Israe

l

Luxe

mbourg

New Zea

land

Netherl

ands

German

y

Greece

Malta

Belgium

Finlan

d

United

Kingdo

m

Denmark

United

States

Cuba

Cyprus

Irelan

d

Portug

al0

500

1000

1500

2000

2500

3000

3500

4000

4500

5000

United States

Page 11: Keynote Presentation: Otis W. Brawley, MD, FACP

Healthcare  in  Three  Countries  (2009)    

•                         Canada  Switzerland      U.S.        •  Infant  Mortality    5.04    4.53          6.22  per  1000  live  births  •  White  Male  Life  Exp  78.0    79.7          76.8  Years  •  Per  Capita  Costs    3173      4011          6096  US  Dollars  •  ProporXon  of  GDP    9.6%      11.2%          17.3%  

Page 12: Keynote Presentation: Otis W. Brawley, MD, FACP

Beyond  Healthcare  Reform  

•  Medicare,  Medicaid,  and  Social  Security  account  for  all  of  the  projected  increase  in  Federal  spending  over  the  next  40  years.  

•  For  the  past  30  years,  costs  per  person  throughout  the  health  care  system  have  been  growing  approximately  two  percentage  points  faster  per  year  than  per-­‐capita  GDP.    

•  Most  projec@ons  assume  this  paaern  will  con@nue  through  2050.  Over  @me,  the  fiscal  consequences  of  this  rate  of  growth  in  health  costs  are  massive.  

Page 13: Keynote Presentation: Otis W. Brawley, MD, FACP

In  order  to  advance  medical  care  

 – We  must  objec@vely  define  the  per@nent  scien@fic  ques@ons  that  need  to  be  addressed  

– We  define  the  per@nent  ques@ons  by  assessing  the  epidemiology  and  clinical  outcomes  

Page 14: Keynote Presentation: Otis W. Brawley, MD, FACP

Toward  an  Efficient  Healthcare  System  

•  Some  consume  too  much    – (Unnecessary  care  given)  

•  Some  consume  too  liale  – (Necessary  care  not  given)  

•  We  could  decrease  the  waste  and  improve  overall  health!!!!  

Page 15: Keynote Presentation: Otis W. Brawley, MD, FACP

The  American  Healthcare  System  

 •  Overconsump@on  of  Healthcare  

•  The  Greedy  Feeding  the  Gluaonous  

•  A  Subtle  form  of  Corrup@on  

Page 16: Keynote Presentation: Otis W. Brawley, MD, FACP

Overuse of Medicine •  Screening (irrational use)

–  Lung Cancer –  Prostate Cancer –  Breast –  Cervix

•  Imaging (CT and MRI)

•  Expensive Drugs (e.g. Nexium vs Omeprazole)

Page 17: Keynote Presentation: Otis W. Brawley, MD, FACP

True  Healthcare  Reform  (An  Efficient,  Value  Driven  Health  System)  

•  Ra@onal  use  of  healthcare  is  necessary  for  the  future  of  the  U.S.  economy  (an  issue  of  U.S.  security)  

•  It  is  possible  to  decrease  costs  and  improve  healthcare  by  using  science  to  guide  our  policies  

Page 18: Keynote Presentation: Otis W. Brawley, MD, FACP

True  Healthcare  Reform  Requires:  

•  The  use  of    “Evidence  Based  Care  and  Preven@on”    

 That  is:  § the  ra@onal  use  of  medicine    § not  the  ra@oning  of  medicine  

•  We  do  what  we  know  works,  and  ogen  do  not  do!  •  We  stop  doing  what  we  know  does  not  work  and  ogen  do!  

Page 19: Keynote Presentation: Otis W. Brawley, MD, FACP

Cancer  Care  

•  An  issue  that  must  be  approached  ethically,  logically  and  ra@onally    

•  We  must  realize:  – What  we  know.  – What  we  do  not  know.  – What  we  believe.  

Page 20: Keynote Presentation: Otis W. Brawley, MD, FACP

“It  is  difficult  to  get  a  man  to  understand  something,  when  his  salary  depends  on  his  not  understanding  it”    

                 Upton  Sinclair  

Page 21: Keynote Presentation: Otis W. Brawley, MD, FACP

Otis W. Brawley, MD, FACP

Chief Medical and Scientific Officer American Cancer Society

Professor of Hematology, Medical Oncology, Medicine and Epidemiology

Emory University

Page 22: Keynote Presentation: Otis W. Brawley, MD, FACP

Rudolph Ludwig Karl Virchow

1821- 1902

Page 23: Keynote Presentation: Otis W. Brawley, MD, FACP

Virchow’s  Accomplishment  

•  One  of  the  first  cellular  pathologists  •  Virchow’s  node  •  Defined  condi@ons  that  cause  thrombosis  •  Defined  cancer  as  a  disease  involving  uncontrolled  

cell  growth  •  The  ini@al  descrip@on  of  leukemia  •  Defined  cancer  using  a  light  microscope  on  

specimens  obtained  on  autopsy  

Page 24: Keynote Presentation: Otis W. Brawley, MD, FACP

Virchow’s  Accomplishments  

     The  defini@on  of  cancer  used  in  2010  is  largely  that  of  Virchow  with  minor  modifica@ons  

         More  than  160  years  later,  we  s@ll  use  his  

defini@ons  using  a  light  microscope.            There  is  clear  evidence  that  some  early  detected  

cancers  do  not  pose  a  threat  and  do  not  need  to  be  treated.  

Page 25: Keynote Presentation: Otis W. Brawley, MD, FACP
Page 26: Keynote Presentation: Otis W. Brawley, MD, FACP

The  future  of  Cancer  Medicine  is  Genomic  

Page 27: Keynote Presentation: Otis W. Brawley, MD, FACP

Prostate  Cancer  and  Chemopreven@on    •  Pretend  you  are  a  55  year  old  male  and  a  preven@ve  pill  exists:  –  If  you  take  the  pill  it  will  definitely  double  your  risk  of  prostate  cancer  diagnosis  from  10%  life@me  to  20%  life@me.  

–  It  you  take  it,  it  may  decrease  your  life@me  risk  of  prostate  cancer  death  by  20%  from  3%  to  2.4%  

•  Would  you  take  this  pill?  

Page 28: Keynote Presentation: Otis W. Brawley, MD, FACP

Otis W. Brawley, MD, FACP

Chief Medical and Scientific Officer American Cancer Society

Professor of Hematology, Medical Oncology, Medicine and Epidemiology

Emory University